{"id":"https://openalex.org/W2012353501","doi":"https://doi.org/10.1111/ejh.12573","title":"Ofatumumab capacity to deplete B cells from chronic lymphocytic leukaemia is affected by C4 complement exhaustion","display_name":"Ofatumumab capacity to deplete B cells from chronic lymphocytic leukaemia is affected by C4 complement exhaustion","publication_year":2015,"publication_date":"2015-04-24","ids":{"openalex":"https://openalex.org/W2012353501","doi":"https://doi.org/10.1111/ejh.12573","mag":"2012353501","pmid":"https://pubmed.ncbi.nlm.nih.gov/25911969"},"language":"en","primary_location":{"id":"doi:10.1111/ejh.12573","doi":"https://doi.org/10.1111/ejh.12573","is_oa":false,"landing_page_url":"https://doi.org/10.1111/ejh.12573","pdf_url":null,"source":{"id":"https://openalex.org/S159715054","display_name":"European Journal Of Haematology","issn_l":"0902-4441","issn":["0902-4441","1600-0609"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Haematology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010574507","display_name":"Adrian Tempescul","orcid":"https://orcid.org/0000-0001-6889-6833","observed_orcids":["https://orcid.org/0000-0001-6889-6833"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210132604","display_name":"Centre Hospitalier R\u00e9gional Universitaire de Brest","ror":"https://ror.org/03evbwn87","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210105774","https://openalex.org/I4210132604","https://openalex.org/I4210161065"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Adrian Tempescul","raw_affiliation_strings":["Department of Clinical Haematology, Institute of Oncology and Haematology, CHRU morvan, Brest, France","INSERM ESPRI ERI29 Laboratory of Immunotherapy and B Cell Diseases Reseau Epigenetique et Reseau Canaux Ioniques du Canc\u00e9ropole Grand Ouest Brest France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Haematology, Institute of Oncology and Haematology, CHRU morvan, Brest, France","institution_ids":["https://openalex.org/I4210132604"]},{"raw_affiliation_string":"INSERM ESPRI ERI29 Laboratory of Immunotherapy and B Cell Diseases Reseau Epigenetique et Reseau Canaux Ioniques du Canc\u00e9ropole Grand Ouest Brest France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023738811","display_name":"Cristina Bagacean","orcid":"https://orcid.org/0000-0001-6061-992X","observed_orcids":["https://orcid.org/0000-0001-6061-992X"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Cristina Bagacean","raw_affiliation_strings":["INSERM ESPRI ERI29 Laboratory of Immunotherapy and B Cell Diseases Reseau Epigenetique et Reseau Canaux Ioniques du Canc\u00e9ropole Grand Ouest Brest France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM ESPRI ERI29 Laboratory of Immunotherapy and B Cell Diseases Reseau Epigenetique et Reseau Canaux Ioniques du Canc\u00e9ropole Grand Ouest Brest France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Catherine Riou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210132604","display_name":"Centre Hospitalier R\u00e9gional Universitaire de Brest","ror":"https://ror.org/03evbwn87","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210105774","https://openalex.org/I4210132604","https://openalex.org/I4210161065"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Catherine Riou","raw_affiliation_strings":["Department of Clinical Haematology, Institute of Oncology and Haematology, CHRU morvan, Brest, France","INSERM ESPRI ERI29 Laboratory of Immunotherapy and B Cell Diseases Reseau Epigenetique et Reseau Canaux Ioniques du Canc\u00e9ropole Grand Ouest Brest France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Haematology, Institute of Oncology and Haematology, CHRU morvan, Brest, France","institution_ids":["https://openalex.org/I4210132604"]},{"raw_affiliation_string":"INSERM ESPRI ERI29 Laboratory of Immunotherapy and B Cell Diseases Reseau Epigenetique et Reseau Canaux Ioniques du Canc\u00e9ropole Grand Ouest Brest France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109400534","display_name":"Boutahar Bendaoud","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Boutahar Bendaoud","raw_affiliation_strings":["INSERM ESPRI ERI29 Laboratory of Immunotherapy and B Cell Diseases Reseau Epigenetique et Reseau Canaux Ioniques du Canc\u00e9ropole Grand Ouest Brest France","Laboratory of Immunology and Immunotherapy CHRU Morvan Brest France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM ESPRI ERI29 Laboratory of Immunotherapy and B Cell Diseases Reseau Epigenetique et Reseau Canaux Ioniques du Canc\u00e9ropole Grand Ouest Brest France","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"Laboratory of Immunology and Immunotherapy CHRU Morvan Brest France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044853634","display_name":"Sophie Hillion","orcid":"https://orcid.org/0000-0002-3354-0981","observed_orcids":["https://orcid.org/0000-0002-3354-0981"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Sophie Hillion","raw_affiliation_strings":["INSERM ESPRI ERI29 Laboratory of Immunotherapy and B Cell Diseases Reseau Epigenetique et Reseau Canaux Ioniques du Canc\u00e9ropole Grand Ouest Brest France","Laboratory of Immunology and Immunotherapy CHRU Morvan Brest France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM ESPRI ERI29 Laboratory of Immunotherapy and B Cell Diseases Reseau Epigenetique et Reseau Canaux Ioniques du Canc\u00e9ropole Grand Ouest Brest France","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"Laboratory of Immunology and Immunotherapy CHRU Morvan Brest France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050588172","display_name":"Marjolaine Debant","orcid":"https://orcid.org/0000-0001-5988-3395","observed_orcids":["https://orcid.org/0000-0001-5988-3395"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Marjolaine Debant","raw_affiliation_strings":["INSERM ESPRI ERI29 Laboratory of Immunotherapy and B Cell Diseases Reseau Epigenetique et Reseau Canaux Ioniques du Canc\u00e9ropole Grand Ouest Brest France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM ESPRI ERI29 Laboratory of Immunotherapy and B Cell Diseases Reseau Epigenetique et Reseau Canaux Ioniques du Canc\u00e9ropole Grand Ouest Brest France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057504409","display_name":"Caroline Buors","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210132604","display_name":"Centre Hospitalier R\u00e9gional Universitaire de Brest","ror":"https://ror.org/03evbwn87","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210105774","https://openalex.org/I4210132604","https://openalex.org/I4210161065"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Caroline Buors","raw_affiliation_strings":["Laboratory of Hematology, CHRU Cavale Blanche, Brest, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Hematology, CHRU Cavale Blanche, Brest, France","institution_ids":["https://openalex.org/I4210132604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109953096","display_name":"Christian Berthou","orcid":"https://orcid.org/0000-0003-1246-5852","observed_orcids":["https://orcid.org/0000-0003-1246-5852"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210132604","display_name":"Centre Hospitalier R\u00e9gional Universitaire de Brest","ror":"https://ror.org/03evbwn87","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210105774","https://openalex.org/I4210132604","https://openalex.org/I4210161065"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Christian Berthou","raw_affiliation_strings":["Department of Clinical Haematology, Institute of Oncology and Haematology, CHRU morvan, Brest, France","INSERM ESPRI ERI29 Laboratory of Immunotherapy and B Cell Diseases Reseau Epigenetique et Reseau Canaux Ioniques du Canc\u00e9ropole Grand Ouest Brest France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Haematology, Institute of Oncology and Haematology, CHRU morvan, Brest, France","institution_ids":["https://openalex.org/I4210132604"]},{"raw_affiliation_string":"INSERM ESPRI ERI29 Laboratory of Immunotherapy and B Cell Diseases Reseau Epigenetique et Reseau Canaux Ioniques du Canc\u00e9ropole Grand Ouest Brest France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085167332","display_name":"Yves Renaudineau","orcid":"https://orcid.org/0000-0001-5098-5002","observed_orcids":["https://orcid.org/0000-0001-5098-5002"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Yves Renaudineau","raw_affiliation_strings":["INSERM ESPRI ERI29 Laboratory of Immunotherapy and B Cell Diseases Reseau Epigenetique et Reseau Canaux Ioniques du Canc\u00e9ropole Grand Ouest Brest France","Laboratory of Immunology and Immunotherapy CHRU Morvan Brest France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM ESPRI ERI29 Laboratory of Immunotherapy and B Cell Diseases Reseau Epigenetique et Reseau Canaux Ioniques du Canc\u00e9ropole Grand Ouest Brest France","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"Laboratory of Immunology and Immunotherapy CHRU Morvan Brest France","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5010574507"],"corresponding_institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210132604"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":null,"fwci":1.6787,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.83336386,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"96","issue":"3","first_page":"229","last_page":"235"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ofatumumab","display_name":"ofatumumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9940000176429749},{"id":"https://openalex.org/keywords/complement-activation","display_name":"complement activation","score":0.7599999904632568},{"id":"https://openalex.org/keywords/anti-cd20-monoclonal-antibody","display_name":"anti-CD20 monoclonal antibody","score":0.9399999976158142},{"id":"https://openalex.org/keywords/b-cell-depletion","display_name":"B-cell depletion","score":0.7699999809265137},{"id":"https://openalex.org/keywords/fcgammariiia-polymorphism","display_name":"Fc\u03b3RIIIa polymorphism","score":0.921999990940094},{"id":"https://openalex.org/keywords/relapsed-refractory-disease","display_name":"relapsed/refractory disease","score":0.8320000171661377},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.6899999976158142},{"id":"https://openalex.org/keywords/dosing-regimen","display_name":"dosing regimen","score":0.6690000295639038}],"concepts":[{"id":"https://openalex.org/C2778714382","wikidata":"https://www.wikidata.org/wiki/Q410656","display_name":"Ofatumumab","level":4,"score":0.9917465448379517},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.810260534286499},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.6756042838096619},{"id":"https://openalex.org/C2780126324","wikidata":"https://www.wikidata.org/wiki/Q612345","display_name":"Lymphocytosis","level":2,"score":0.6185559034347534},{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.6067066788673401},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5061606764793396},{"id":"https://openalex.org/C113067387","wikidata":"https://www.wikidata.org/wiki/Q14912836","display_name":"CD5","level":3,"score":0.4963567852973938},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.49365028738975525},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.4647976756095886},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.40600383281707764},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.31589174270629883},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.2622729241847992},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.06061214208602905},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001402","descriptor_name":"B-Lymphocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001402","descriptor_name":"B-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D001402","descriptor_name":"B-Lymphocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003176","descriptor_name":"Complement C3","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D003181","descriptor_name":"Complement C4","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007223","descriptor_name":"Infant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008212","descriptor_name":"Lymphocyte Depletion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011110","descriptor_name":"Polymorphism, Genetic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D016130","descriptor_name":"Immunophenotyping","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017452","descriptor_name":"Receptors, IgG","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/ejh.12573","doi":"https://doi.org/10.1111/ejh.12573","is_oa":false,"landing_page_url":"https://doi.org/10.1111/ejh.12573","pdf_url":null,"source":{"id":"https://openalex.org/S159715054","display_name":"European Journal Of Haematology","issn_l":"0902-4441","issn":["0902-4441","1600-0609"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Haematology","raw_type":"journal-article"},{"id":"pmid:25911969","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25911969","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of haematology","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-01515374v1","doi":null,"is_oa":false,"landing_page_url":"https://hal.science/hal-01515374","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"European Journal of Haematology, 2015, 96 (3), pp.229-35","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322363","display_name":"Ligue Contre le Cancer","ror":"https://ror.org/00rkrv905"},{"id":"https://openalex.org/F4320332162","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W154103547","https://openalex.org/W1593874097","https://openalex.org/W1721657566","https://openalex.org/W1914229355","https://openalex.org/W1965851569","https://openalex.org/W1968451317","https://openalex.org/W1970856888","https://openalex.org/W1977422931","https://openalex.org/W1994709165","https://openalex.org/W2005365816","https://openalex.org/W2016973656","https://openalex.org/W2044360617","https://openalex.org/W2047973997","https://openalex.org/W2049353008","https://openalex.org/W2056376654","https://openalex.org/W2132238257","https://openalex.org/W2141139539","https://openalex.org/W2142099365","https://openalex.org/W2146289907","https://openalex.org/W2147639736","https://openalex.org/W2158803162","https://openalex.org/W2166117556","https://openalex.org/W2333847799","https://openalex.org/W2397284397","https://openalex.org/W4313146863"],"related_works":["https://openalex.org/W4256090601","https://openalex.org/W3049768172","https://openalex.org/W2294390837","https://openalex.org/W2052884812","https://openalex.org/W2132467087","https://openalex.org/W2145402798","https://openalex.org/W2005892644","https://openalex.org/W2052868810","https://openalex.org/W1968451317","https://openalex.org/W2327112526"],"abstract_inverted_index":{"The":[0],"management":[1],"of":[2,14,25,36,53,69,89,97,124],"patients":[3,27,62,99,129,145,205],"with":[4,11,63,130,146,179,206],"chronic":[5],"lymphocytic":[6],"leukaemia":[7],"(CLL)":[8],"has":[9],"improved":[10,157],"the":[12,26,32,34,51,67,70,103],"utilisation":[13],"ofatumumab":[15,113,155,189],"as":[16,23],"a":[17,119,138],"novel":[18],"anti-CD20":[19],"monoclonal":[20],"antibody.":[21],"However,":[22],"half":[24],"fail":[28],"to":[29,31,40,50,118,153,197],"respond":[30],"treatment,":[33,71],"aim":[35],"this":[37],"study":[38],"was":[39,81,135,176],"evaluate":[41],"circulating":[42,75,148,183],"CLL":[43,61,78,158,184,204],"cell":[44,79,159,185],"depletion":[45,80,160],"and":[46,56,100,121,141,171],"clinical":[47,108],"response":[48],"according":[49],"context":[52],"complement":[54,125],"activation":[55],"Fc\u03b3RIIIA":[57,164],"polymorphism":[58,166],"in":[59,87,95,128,137,143,161],"ten":[60],"relapsed/refractory":[64],"disease.":[65],"At":[66],"end":[68],"results":[72],"indicated":[73],"that":[74,195],"CD5(+)":[76],"CD19(+)":[77],"major":[82,180],"(<0.01":[83],"\u00d7":[84],"10(9)":[85],"/L)":[86],"4":[88,96],"10":[90,98],"patients,":[91],"partial":[92,147,182],"(>50%":[93],"decrease)":[94],"ineffective":[101],"for":[102],"two":[104,144,162],"other":[105],"patients.":[106,163],"No":[107],"modifications":[109],"were":[110],"observed":[111],"following":[112],"introduction.":[114],"Ofatumumab":[115],"administration":[116],"leads":[117],"rapid":[120],"important":[122,192],"exhaustion":[123,134,194],"C4":[126,133,193],"levels":[127],"initial":[131],"lymphocytosis.":[132],"accelerated":[136],"non-responder":[139],"patient,":[140],"incomplete":[142],"depletion.":[149,186],"Moreover,":[150],"delaying":[151],"weekly":[152],"monthly":[154],"injections":[156],"158":[165],"(FF":[167],"n":[168,173],"=":[169,174],"6":[170],"VF":[172],"4)":[175],"not":[177],"associated":[178],"and/or":[181],"In":[187],"conclusion,":[188],"induces":[190],"an":[191],"needs":[196],"be":[198],"taken":[199],"into":[200],"account":[201],"when":[202],"treating":[203],"ofatumumab.":[207]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}